European Market Report for Port Needles 2017 - MedCore

  • ID: 3960389
  • Report
  • Region: Europe
  • 129 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Over the forecast period, the total port needle market is expected to experience growth. The increase in market value will be driven by growth in the size and age of the European population and the corresponding rise in demand for cancer treatment. Growth will be limited by ASP erosion. Price declines will be driven by competition amongst firms and a lack of technological innovation. Price erosion will be limited by growth in the alternate care market as well as the conversion to safety port needles.

Port needles or Huber needles are used exclusively for accessing implantable ports; therefore, there is a strong correlation between the sales of these two devices. While ports are primarily implanted in hospitals, port needles are widely used in alternate care sites. Improved designs of port needles are allowing patients to refill and maintain their implantable ports on their own or with minimal help from family or clinical staff. However, many port patients must visit a hospital to receive treatment because they require monitoring or assistance, particularly if their medication has potential side effects.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Table Of Contents I
List Of Figures Xvi
List Of Charts Xx
Executive Summary
European Market For Vascular Access Devices And Accessories Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Basic Anatomy
2.1.1 Human Vascular System
2.2 Vascular Pathology And Disorders
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
Product Assessment
3.1 Product Portfolios
3.1.1 Port Needles
3.1.1.1 Introduction
3.1.1.2 Angiodynamics
3.1.1.2.1 Lifeguard®
3.1.1.2.2 Lifeport®
3.1.1.3 B. Braun
3.1.1.3.1 Whin®
3.1.1.4 Cook Medical
3.1.1.4.1 Vital-Ject™
3.1.1.5 C. R. Bard
3.1.1.5.1 Powerloc®
3.1.1.5.2 Other Port Needle Offerings
3.1.1.6 Kawasumi
3.1.1.6.1 K-Shield®
3.1.1.6.2 Other Port Needle Offerings
3.1.1.7 Mps Medical, Inc.
3.1.1.7.1 Smartsafety®
3.1.1.8 Nipro Medical
3.1.1.8.1 Safetouch™
3.1.1.9 Smiths Medical
3.1.1.9.1 Gripper®
3.1.1.9.2 Gripper Plus®
3.1.1.9.3 Other Port Needle Offerings
3.1.1.10 Vygon (Churchill Medical Systems)
3.1.1.10.1 Lifeguard™
3.1.1.10.2 Wing Safe™
3.2 Regulatory Issues And Recalls
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 Product Pipelines
3.3.1 Alliance Vascular Devices, Llc
3.3.1.1 Freehand Safety Huber Needle®
3.3.2 Angiodynamics
3.3.2.1 Celerity™ Picc Tip Confirmation System With Navigation
3.3.2.2 Firefly
3.3.2.3 Bioflo® Picc Line Extension
3.3.2.4 Bioflo® Port Line Extension
3.3.2.5 Next Generation Bioflo® Picc
3.3.2.6 Next Generation Bioflo® Port
3.3.3 Bluegrass Vascular Technologies, Inc.
3.3.3.1 Surfacer® Inside-Out™ Access System
3.3.4 C.R. Bard
3.3.4.1 Chemical-Resistant Piccs
3.3.4.2 Novel Advanced Material Piccs
3.3.4.3 Powerglide® Pro Midline
3.3.4.4 Accucath®
3.3.4.5 Xenesis™ Acute Hemodialysis Catheter
3.3.4.6 Site~Rite® 8 Ultrasound System
3.3.5 M. C. Johnson
3.3.5.1 Picc Securement Device
3.3.6 Nipro Medical
3.3.6.1 Shielding Safety Needle
3.3.6.2 Safety Syringe
3.3.6.3 Safety Pivc
3.3.7 Parasol Medical
3.3.7.1 Catheter Securement Device
3.3.8 Pavmed Inc.
3.3.8.1 Nextcath™
3.3.9 Phase One Medical
3.3.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.3.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.3.10 Prodigy Diabetes Care, Llc.
3.3.10.1 Insulin Pen Needles
3.3.11 Sharklet Technologies, Inc.
3.3.11.1 Sharklet™ Central Venous Catheter
3.3.12 Starboard Medical
3.3.12.1 Catheter Securement Devices
3.3.13 Teleflex Medical
3.3.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.3.13.2 Tip Confirmation For Cvcs, Chronic Hemodialysis Catheters & Ports
3.3.14 Vascular Access Technologies, Inc.
3.3.14.1 Safecvad™
Country Profiles
4.1 Introduction
4.1.1 Population
4.1.2 Gdp Per Capita
4.1.3 Price Index
4.2 Germany
4.3 France
4.4 United Kingdom
4.5 Italy
4.6 Spain
4.7 Benelux
4.8 Scandinavia
4.9 Austria
4.10 Switzerland
4.11 Portugal
Port Needle Market
5.1 Introduction
5.1.1 Safety Port Needles
5.1.2 Power-Injectable Port Needles
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Total Port Needle Market
5.3.2 Conventional Port Needle Market
5.3.3 Safety Port Needle Market
5.3.3.1 Power-Injectable Safety Port Needle Market
5.3.3.2 Non-Power-Injectable Safety Port Needle Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
Abbreviations
Appendix: Company Press Releases
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
The European market for port needles include conventional and safety port needles. Safety port needles include power-injectable and non-power-injectable port needles that feature a needlestick prevention mechanism. The value of the port needle market has appreciated in recent years. The implementation of legislation designed to prevent needlestick injuries in hospitals has led to increasing sales of safety port needles and a spike in the overall port needle market from 2012.
Note: Product cover images may vary from those shown
5 of 5
3DT Holdings LLC
3M
Access Scientific
Ambu Inc.
AngioDynamics
Artsana
B. Braun
Baxter International
Becton Dickinson
Bionic
C. R. Bard
Cardinal Health
CareFusion
Codan
Cook Medical
Covidien
Deltamed
Districlass Medical
Edwards Lifesciences
Endeavor Capital
Fresenius
Grupo Sendal
Interrad Medical
Investindustrial
Ivera Medical Corporation
Joline
Kimal
LPI
Medcomp
Medikit
Medtronic
Navilyst Medical
Nipro Medical
Nostix, LLC
Novico
Pentaferte
Perouse Medical
PFM Medical
PFM Medical
PositiveID Corp.
Rays
Romedex
Roundtable Healthcare
Safety Syringes Inc.
Semprus BioSciences
Smiths Medical
SonoSite, Inc.
Teleflex Medical
Terumo
Troge
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
VigMed
V-Tech
Vygon
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll